David Springer, GID BIO - Cellular Therapy Development | LSI Europe '25

GID BIO is a biotechnology company dedicated to advancing innovative cellular therapies aimed at revolutionizing patient care and improving quality of life. Leveraging cutting-edge technology and research, they focus on delivering transformative solutions for complex medical conditions.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach